Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Oct;119(4):758–764. doi: 10.1111/j.1476-5381.1996.tb15737.x

Interaction of the islet nitric oxide system with L-arginine-induced secretion of insulin and glucagon in mice.

B Akesson 1, H Mosén 1, G Panagiotidis 1, I Lundquist 1
PMCID: PMC1915775  PMID: 8904652

Abstract

1. Several recent in vitro studies have suggested that production of nitric oxide (NO) from the islet NO system may have an important regulatory influence on the secretion of insulin and glucagon. In the present paper we have investigated, mainly with an in vivo approach, the influence and specificity of the NO synthase (NOS) blocker NG-nitro-L-arginine methyl ester (L-NAME) on L-arginine-induced secretion of insulin and glucagon. 2. In freely fed mice, L-NAME pretreatment (1.2 mmol kg-1) influenced the dynamics of insulin and glucagon release following an equimolar dose of L-arginine, the specific substrate for NOS activity, in that the NOS inhibitor enhanced the insulin response but suppressed the glucagon responses. This was reflected in a large decrease in the plasma glucose levels of the L-NAME pretreated animals. 3. L-NAME pretreatment did not influence the insulin and glucagon secretory responses to the L-arginine-enantiomer D-arginine, which cannot serve as a substrate for NOS activity. 4. Replacing L-NAME pretreatment by pretreatment with D-arginine or L-arginine itself, which both carry the same cationic change and are devoid of NOS inhibitory properties, did not mimic the effects of L-NAME on L-arginine-induced hormone release. 5. Fasting the animals for 24 h totally abolished the L-NAME-induced potentiation of L-arginine stimulated insulin release suggesting that the sensitivity of the beta-cell secretory machinery to NO-production is greatly changed in the fasting state. However, the L-NAME-induced suppression of L-arginine stimulated glucagon release was unaffected by starvation. 6. In isolated islets from freely fed mice, L-arginine (5 mM) stimulated insulin release was greatly enhanced and glucagon release markedly suppressed by the presence of the NOS inhibitor L-NAME in the incubation medium. These effects were abolished in isolated islets taken from 24 h fasted mice. 7. Our present results, which showed that the NOS inhibitor L-NAME markedly enhances insulin release but suppresses glucagon release induced by L-arginine in the intact animal, give strong support to our previous hypothesis that the islet NO system is a negative modulator of insulin secretion and a positive modulator of glucagon secretion. Additionally, we observed that the importance of the beta-cell NO-production for secretory mechanisms, as evaluated by the effect of L-NAME on L-arginine-induced insulin release, was greatly changed after starvation, an effect less prominent with regard to glucagon release.

Full text

PDF
758

Images in this article

761Figure 2
on p.761
761Figure 3
on p.761

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahrén B., Lundquist I. Glucagon immunoreactivity in plasma from normal and dystrophic mice. Diabetologia. 1982 Apr;22(4):258–263. doi: 10.1007/BF00281302. [DOI] [PubMed] [Google Scholar]
  2. Antoine M. H., Hermann M., Herchuelz A., Lebrun P. Sodium nitroprusside inhibits glucose-induced insulin release by activating ATP-sensitive K+ channels. Biochim Biophys Acta. 1993 Feb 17;1175(3):293–301. doi: 10.1016/0167-4889(93)90220-j. [DOI] [PubMed] [Google Scholar]
  3. Bouwens L., Klöppel G. Cytochemical localization of NADPH-diaphorase in the four types of pancreatic islet cell. Histochemistry. 1994 Mar;101(3):209–214. doi: 10.1007/BF00269546. [DOI] [PubMed] [Google Scholar]
  4. Bruss M. L., Black A. L. Enzymatic microdetermination of glycogen. Anal Biochem. 1978 Jan;84(1):309–312. doi: 10.1016/0003-2697(78)90514-6. [DOI] [PubMed] [Google Scholar]
  5. Corbett J. A., Wang J. L., Misko T. P., Zhao W., Hickey W. F., McDaniel M. L. Nitric oxide mediates IL-1 beta-induced islet dysfunction and destruction: prevention by dexamethasone. Autoimmunity. 1993;15(2):145–153. doi: 10.3109/08916939309043889. [DOI] [PubMed] [Google Scholar]
  6. Cunningham J. M., Mabley J. G., Delaney C. A., Green I. C. The effect of nitric oxide donors on insulin secretion, cyclic GMP and cyclic AMP in rat islets of Langerhans and the insulin-secreting cell lines HIT-T15 and RINm5F. Mol Cell Endocrinol. 1994 Jun;102(1-2):23–29. doi: 10.1016/0303-7207(94)90093-0. [DOI] [PubMed] [Google Scholar]
  7. Förstermann U., Schmidt H. H., Pollock J. S., Sheng H., Mitchell J. A., Warner T. D., Nakane M., Murad F. Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem Pharmacol. 1991 Oct 24;42(10):1849–1857. doi: 10.1016/0006-2952(91)90581-o. [DOI] [PubMed] [Google Scholar]
  8. Gotoh M., Maki T., Kiyoizumi T., Satomi S., Monaco A. P. An improved method for isolation of mouse pancreatic islets. Transplantation. 1985 Oct;40(4):437–438. doi: 10.1097/00007890-198510000-00018. [DOI] [PubMed] [Google Scholar]
  9. Gross R., Roye M., Manteghetti M., Hillaire-Buys D., Ribes G. Alterations of insulin response to different beta cell secretagogues and pancreatic vascular resistance induced by N omega-nitro-L-arginine methyl ester. Br J Pharmacol. 1995 Oct;116(3):1965–1972. doi: 10.1111/j.1476-5381.1995.tb16399.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hedeskov C. J. Mechanism of glucose-induced insulin secretion. Physiol Rev. 1980 Apr;60(2):442–509. doi: 10.1152/physrev.1980.60.2.442. [DOI] [PubMed] [Google Scholar]
  11. Hellman B., Gylfe E., Bergsten P., Grapengiesser E., Lund P. E., Berts A., Dryselius S., Tengholm A., Liu Y. J., Eberhardson M. The role of Ca2+ in the release of pancreatic islet hormones. Diabete Metab. 1994 Mar-Apr;20(2):123–131. [PubMed] [Google Scholar]
  12. Jansson L., Sandler S. The nitric oxide synthase II inhibitor NG-nitro-L-arginine stimulates pancreatic islet insulin release in vitro, but not in the perfused pancreas. Endocrinology. 1991 Jun;128(6):3081–3085. doi: 10.1210/endo-128-6-3081. [DOI] [PubMed] [Google Scholar]
  13. Jones P. M., Persaud S. J., Bjaaland T., Pearson J. D., Howell S. L. Nitric oxide is not involved in the initiation of insulin secretion from rat islets of Langerhans. Diabetologia. 1992 Nov;35(11):1020–1027. doi: 10.1007/BF02221676. [DOI] [PubMed] [Google Scholar]
  14. Knowles R. G., Moncada S. Nitric oxide synthases in mammals. Biochem J. 1994 Mar 1;298(Pt 2):249–258. doi: 10.1042/bj2980249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Laychock S. G., Modica M. E., Cavanaugh C. T. L-arginine stimulates cyclic guanosine 3',5'-monophosphate formation in rat islets of Langerhans and RINm5F insulinoma cells: evidence for L-arginine:nitric oxide synthase. Endocrinology. 1991 Dec;129(6):3043–3052. doi: 10.1210/endo-129-6-3043. [DOI] [PubMed] [Google Scholar]
  16. Lundquist I., Fanska R., Grodsky G. M. Direct calcium-stimulated release of glucagon from the isolation perfused rat pancreas and the effect of chemical sympathectomy. Endocrinology. 1976 Mar;98(3):815–818. doi: 10.1210/endo-98-3-815. [DOI] [PubMed] [Google Scholar]
  17. Lundquist I. Islet amyloglucosidase activity: some characteristics, and its relation to insulin secretion stimulated by various secretagogues. Diabetes Res. 1986 Jan;3(1):31–41. [PubMed] [Google Scholar]
  18. Lundquist I., Lövdahl R. Effect of fasting on islet lysosomal enzyme activities and the in vivo insulin response to different secretagogues. Horm Metab Res. 1983 Jan;15(1):11–14. doi: 10.1055/s-2007-1018615. [DOI] [PubMed] [Google Scholar]
  19. Lundquist I., Panagiotidis G., Stenström A. Effect of L-dopa administration on islet monoamine oxidase activity and glucose-induced insulin release in the mouse. Pancreas. 1991 Sep;6(5):522–527. doi: 10.1097/00006676-199109000-00004. [DOI] [PubMed] [Google Scholar]
  20. Maruyama H., Hisatomi A., Orci L., Grodsky G. M., Unger R. H. Insulin within islets is a physiologic glucagon release inhibitor. J Clin Invest. 1984 Dec;74(6):2296–2299. doi: 10.1172/JCI111658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 Jun;43(2):109–142. [PubMed] [Google Scholar]
  22. Panagiotidis G., Akesson B., Rydell E. L., Lundquist I. Influence of nitric oxide synthase inhibition, nitric oxide and hydroperoxide on insulin release induced by various secretagogues. Br J Pharmacol. 1995 Jan;114(2):289–296. doi: 10.1111/j.1476-5381.1995.tb13225.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Panagiotidis G., Lindström P., Stenström A., Lundquist I. Glucose modulation of islet monoamine oxidase activity in lean and obese hyperglycemic mice. Metabolism. 1993 Nov;42(11):1398–1404. doi: 10.1016/0026-0495(93)90189-u. [DOI] [PubMed] [Google Scholar]
  24. Panagiotidis G., Salehi A. A., Westermark P., Lundquist I. Homologous islet amyloid polypeptide: effects on plasma levels of glucagon, insulin and glucose in the mouse. Diabetes Res Clin Pract. 1992 Dec;18(3):167–171. doi: 10.1016/0168-8227(92)90142-e. [DOI] [PubMed] [Google Scholar]
  25. Panagiotidis G., Stenström A., Lundquist I. Effects of adrenergic and cholinergic stimulation on islet monoamine oxidase activity and insulin secretion in the mouse. Eur J Pharmacol. 1993 Mar 23;233(2-3):285–290. doi: 10.1016/0014-2999(93)90063-n. [DOI] [PubMed] [Google Scholar]
  26. Panagiotidis G., Stenström A., Lundquist I. Influence of beta 2-adrenoceptor stimulation and glucose on islet monoamine oxidase activity and insulin secretory response in the mouse. Pancreas. 1993 May;8(3):368–374. doi: 10.1097/00006676-199305000-00014. [DOI] [PubMed] [Google Scholar]
  27. Rerup C., Lundquist I. Blood glucose level in mice. 1. Evaluation of a new technique of multiple serial sampling. Acta Endocrinol (Copenh) 1966 Jul;52(3):357–367. [PubMed] [Google Scholar]
  28. Sandler S., Eizirik D. L., Svensson C., Strandell E., Welsh M., Welsh N. Biochemical and molecular actions of interleukin-1 on pancreatic beta-cells. Autoimmunity. 1991;10(3):241–253. doi: 10.3109/08916939109001895. [DOI] [PubMed] [Google Scholar]
  29. Schmidt H. H., Warner T. D., Ishii K., Sheng H., Murad F. Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides. Science. 1992 Feb 7;255(5045):721–723. doi: 10.1126/science.1371193. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES